Medical Equipment

Smart Tissue Autonomous Robot (STAR) Market Size and Demand Forecast 2026–2030

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the smart tissue autonomous robot (star) market from 2026–2035 with trusted insights from The Business Research Company

How much is the Smart Tissue Autonomous Robot (STAR) Market valued at in 2026, and what valuation is forecast for 2030?

The market size for the smart tissue autonomous robot (star) has experienced significant expansion in recent years. It is anticipated to increase from $0.3 billion in 2025 to $0.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 20.3%. The historic growth of this market is attributable to developments such as growth in robotic surgery platforms, minimally invasive surgery demand, surgical imaging advances, hospital robotics investments, and precision surgery requirements.

The market size for smart tissue autonomous robots (STAR) is anticipated to experience rapid expansion over the coming years. This market is projected to reach $0.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 20.5%. Factors contributing to this growth during the forecast period include the expanding research in autonomous surgery, the integration of AI into surgical workflows, the increasing demand for advanced sensing instruments, a heightened focus on reproducible surgery outcomes, and enhanced funding for next-generation surgical robotics. Key trends expected within the forecast period encompass autonomous soft tissue suturing systems, AI-guided surgical decision engines, real-time tissue tracking robotics, force feedback surgical instruments, and image-driven robotic navigation.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33322&type=smp

What Drivers Are Influencing The Growth Of The Smart Tissue Autonomous Robot (STAR) Market?

The increasing need for minimally invasive surgical procedures is anticipated to fuel the expansion of the smart tissue autonomous robot (STAR) market. Such procedures involve operations conducted via tiny cuts or natural orifices, employing specific tools to lessen tissue damage, blood loss, and recuperation periods, all while upholding surgical accuracy. This surge in demand stems from improved patient safety. The smart tissue autonomous robot (STAR) facilitates this growing demand for minimally invasive surgeries by accurately carrying out intricate soft-tissue tasks through small incisions, thereby decreasing human errors, reducing tissue harm, and boosting overall surgical precision and patient recovery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, hyaluronic acid filler minimally invasive procedures totaled 5.29 million in 2023, an 8% increase over 2022. Consequently, the escalating requirement for minimally invasive surgical procedures is propelling the growth of the smart tissue autonomous robot (STAR) market. The increasing capital allocated by hospitals towards robotic infrastructure is projected to advance the smart tissue autonomous robot (STAR) market. Robotic infrastructure encompasses the entire suite of robotic systems, along with the necessary software, hardware, and physical spaces required for the efficient deployment, operation, and upkeep of robotic technologies within a healthcare institution. This rise in hospital investments in robotic infrastructure is motivated by the objective of enhancing surgical precision. The smart tissue autonomous robot (STAR) aids these growing hospital investments by providing a sophisticated autonomous surgical platform that combines artificial intelligence, imaging, and precise robotics, thereby allowing hospitals to improve their surgical capabilities, achieve better clinical outcomes, and optimize the return on their robotic technology investments. For instance, in Nov 2025, according to Springer Nature, a Germany-based academic and scientific publishing company, reported that surgical robot ownership among trusts rose by 42% from 36 to 51, with usage expanding to 49 trusts for general surgery and doubling for emergency procedures from 13 to 26 trusts. Thus, the expansion of hospital investments in robotic infrastructure is stimulating the growth of the smart tissue autonomous robot (STAR) market.

How Is The Smart Tissue Autonomous Robot (STAR) Market Organized Into Various Segments?

The smart tissue autonomous robot (star) market covered in this report is segmented –

1) By Component: Hardware; Software

2) By Surgical Technique: Open Surgery; Minimally Invasive Surgery; Endoscopic Surgery

3) By Technology: Artificial Intelligence; Machine Learning; Computer Vision; Robotic Manipulation

4) By Application: Soft Tissue Surgery; Plastic And Reconstructive Surgery; Orthopedic Surgery; Gastrointestinal Surgery; Cardiothoracic Surgery

5) By End-User: Hospitals; Ambulatory Surgical Centers; Research Institutions; Clinics

Subsegments:

1) By Hardware: Sensors; Actuators; Robotic Arms; Control Units; Imaging Modules; Power Systems

2) By Software: Algorithmic Control Software; Machine Learning Platforms; Surgical Planning Software; Real Time Navigation Software; Image Processing Software; Data Analytics Software

Who Are The Core Companies Influencing Trends In The Smart Tissue Autonomous Robot (STAR) Market?

Major companies operating in the smart tissue autonomous robot (star) market are Johnson & Johnson, Medtronic, ABB Ltd, Siemens Healthineers, Stryker Corporation, Philips, Boston Scientific, Zimmer Biomet Holdings, Inc., Intuitive Surgical, Smith & Nephew plc, KARL STORZ, Globus Medical, Inc., Renishaw plc, CMR Surgical Limited, Osso VR, Caresyntax, Think Surgical, Inc, Activ Surgical, Tuodao Medical, Sina Robotics & Medical Innovators Co

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/smart-tissue-autonomous-robot-star-market-report

Which Regions Are Projected To Dominate The Smart Tissue Autonomous Robot (STAR) Market In The Coming Years?

North America was the largest region in the smart tissue autonomous robot (STAR) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart tissue autonomous robot (star) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Smart Tissue Autonomous Robot (STAR) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33322&type=smp

Browse Through More Reports Similar to the Global Smart Tissue Autonomous Robot (STAR) Market 2026, By The Business Research Company

Medical Robots Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-robots-global-market-report

Medical Robotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-robotics-global-market-report

Surgical Robots Market Report 2026

https://www.thebusinessresearchcompany.com/report/surgical-robots-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795